Dynatronics (DYNT) Competitors $0.09 0.00 (0.00%) As of 08/8/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsSEC FilingsShort InterestTrendsBuy This Stock DYNT vs. QNRX, NDRA, CHEK, VERO, TIVC, AEMD, XAGE, GCTK, BLAC, and LGMKShould you be buying Dynatronics stock or one of its competitors? The main competitors of Dynatronics include Quoin Pharmaceuticals (QNRX), ENDRA Life Sciences (NDRA), Check-Cap (CHEK), Venus Concept (VERO), Tivic Health Systems (TIVC), Aethlon Medical (AEMD), Longevity Health (XAGE), GlucoTrack (GCTK), Bellevue Life Sciences Acquisition (BLAC), and LogicMark (LGMK). These companies are all part of the "medical equipment" industry. Dynatronics vs. Its Competitors Quoin Pharmaceuticals ENDRA Life Sciences Check-Cap Venus Concept Tivic Health Systems Aethlon Medical Longevity Health GlucoTrack Bellevue Life Sciences Acquisition LogicMark Quoin Pharmaceuticals (NASDAQ:QNRX) and Dynatronics (NASDAQ:DYNT) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership. Do institutionals & insiders believe in QNRX or DYNT? 8.6% of Quoin Pharmaceuticals shares are owned by institutional investors. Comparatively, 4.2% of Dynatronics shares are owned by institutional investors. 13.5% of Quoin Pharmaceuticals shares are owned by insiders. Comparatively, 8.0% of Dynatronics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is QNRX or DYNT more profitable? Quoin Pharmaceuticals has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Dynatronics' return on equity of -41.81% beat Quoin Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Quoin PharmaceuticalsN/A -177.45% -91.15% Dynatronics -8.35%-41.81%-9.56% Which has stronger earnings and valuation, QNRX or DYNT? Dynatronics has higher revenue and earnings than Quoin Pharmaceuticals. Quoin Pharmaceuticals is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQuoin PharmaceuticalsN/AN/A-$8.96M-$48.81-0.15Dynatronics$33.60M0.03-$2.70M-$0.78-0.11 Which has more volatility & risk, QNRX or DYNT? Quoin Pharmaceuticals has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500. Comparatively, Dynatronics has a beta of 0.49, suggesting that its stock price is 51% less volatile than the S&P 500. Does the media favor QNRX or DYNT? In the previous week, Quoin Pharmaceuticals had 3 more articles in the media than Dynatronics. MarketBeat recorded 3 mentions for Quoin Pharmaceuticals and 0 mentions for Dynatronics. Quoin Pharmaceuticals' average media sentiment score of 1.00 beat Dynatronics' score of 0.00 indicating that Quoin Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Quoin Pharmaceuticals Positive Dynatronics Neutral SummaryQuoin Pharmaceuticals and Dynatronics tied by winning 6 of the 12 factors compared between the two stocks. Get Dynatronics News Delivered to You Automatically Sign up to receive the latest news and ratings for DYNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DYNT vs. The Competition Export to ExcelMetricDynatronicsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.16M$72.83M$5.45B$9.62BDividend YieldN/AN/A4.61%4.14%P/E Ratio-0.119.5029.8424.85Price / Sales0.03104.73450.0298.74Price / CashN/A18.4136.4258.36Price / Book0.156.798.185.64Net Income-$2.70M-$25.86M$3.26B$265.87M7 Day PerformanceN/A6.39%6.11%5.06%1 Month PerformanceN/A3.83%0.93%1.43%1 Year PerformanceN/A47.52%28.85%22.53% Dynatronics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DYNTDynatronicsN/A$0.09flatN/A-48.2%$1.16M$33.60M-0.11200QNRXQuoin Pharmaceuticals2.0398 of 5 stars$6.91+3.1%N/A-61.2%$4.07MN/A-0.144News CoverageEarnings ReportGap UpNDRAENDRA Life Sciences1.7475 of 5 stars$5.22+2.4%$50.00+857.9%-99.9%$3.92MN/A-0.0320Positive NewsUpcoming EarningsGap DownCHEKCheck-CapN/A$0.64-2.5%N/A-64.9%$3.72MN/A-0.2180Positive NewsVEROVenus Concept1.4786 of 5 stars$2.52+1.6%N/A-65.7%$3.58M$64.83M-0.03410Positive NewsUpcoming EarningsTIVCTivic Health SystemsN/A$3.42+6.5%N/A-54.9%$3.56M$516K0.0010Positive NewsUpcoming EarningsAEMDAethlon Medical1.2605 of 5 stars$1.20-0.8%$56.00+4,566.7%-50.3%$3.10MN/A-0.0910Upcoming EarningsXAGELongevity HealthN/A$2.93+3.2%N/AN/A$2.93M$50K0.0014Analyst UpgradeGCTKGlucoTrack0.5516 of 5 stars$5.98-0.7%N/A-99.5%$2.87MN/A-0.115Positive NewsBLACBellevue Life Sciences AcquisitionN/A$0.64-6.7%N/A-94.3%$2.60MN/A0.00N/AHigh Trading VolumeLGMKLogicMark0.2153 of 5 stars$0.00-19.2%N/A-99.9%$2.42M$9.88M0.0020Positive NewsUpcoming EarningsGap Up Related Companies and Tools Related Companies Quoin Pharmaceuticals Competitors ENDRA Life Sciences Competitors Check-Cap Competitors Venus Concept Competitors Tivic Health Systems Competitors Aethlon Medical Competitors Longevity Health Competitors GlucoTrack Competitors Bellevue Life Sciences Acquisition Competitors LogicMark Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DYNT) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dynatronics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dynatronics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DYNT Stock Alerts